Trial Outcomes & Findings for Film Array Gastrointestinal Panel Compared to Usual Care for ED Evaluation of Infectious Diarrhea (NCT NCT03809117)

NCT ID: NCT03809117

Last Updated: 2022-12-20

Results Overview

Optimal use of antibiotics is defined as the most appropriate antibiotic to treat a specified pathogen. Designated physicians on study staff will retrospectively examine charts of enrolled subjects will evaluate whether the antibiotic chosen by treating clinician was appropriate given GI PCR results.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

74 participants

Primary outcome timeframe

30 Days post ED Discharge

Results posted on

2022-12-20

Participant Flow

Participant milestones

Participant milestones
Measure
Experimental
Gastrointestinal Polymerase Chain Reaction test performed and results communicated to treatment provider. Followed by usual care per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
Control
Gastrointestinal Polymerase Chain Reaction test performed at the conclusion of the study. Clinician will not be informed of results. Usual Care performed per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
Overall Study
STARTED
38
36
Overall Study
COMPLETED
38
36
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Film Array Gastrointestinal Panel Compared to Usual Care for ED Evaluation of Infectious Diarrhea

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Experimental
n=38 Participants
Gastrointestinal Polymerase Chain Reaction test performed and results communicated to treatment provider. Followed by usual care per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
Control
n=36 Participants
Gastrointestinal Polymerase Chain Reaction test performed at the conclusion of the study. Clinician will not be informed of results. Usual Care performed per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
Total
n=74 Participants
Total of all reporting groups
Age, Continuous
34 years
n=5 Participants
33 years
n=7 Participants
34 years
n=5 Participants
Sex: Female, Male
Female
23 Participants
n=5 Participants
19 Participants
n=7 Participants
42 Participants
n=5 Participants
Sex: Female, Male
Male
15 Participants
n=5 Participants
17 Participants
n=7 Participants
32 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Black
21 Participants
n=5 Participants
21 Participants
n=7 Participants
42 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · White
10 Participants
n=5 Participants
9 Participants
n=7 Participants
19 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Asian, Native American, Other, Unknown
7 Participants
n=5 Participants
6 Participants
n=7 Participants
13 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 30 Days post ED Discharge

Optimal use of antibiotics is defined as the most appropriate antibiotic to treat a specified pathogen. Designated physicians on study staff will retrospectively examine charts of enrolled subjects will evaluate whether the antibiotic chosen by treating clinician was appropriate given GI PCR results.

Outcome measures

Outcome measures
Measure
Experimental
n=38 Participants
Gastrointestinal Polymerase Chain Reaction test performed and results communicated to treatment provider. Followed by usual care per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
Control
n=36 Participants
Gastrointestinal Polymerase Chain Reaction test performed at the conclusion of the study. Clinician will not be informed of results. Usual Care performed per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
Number of Participants With Optimal Antibiotic Chosen
13 Participants
8 Participants

SECONDARY outcome

Timeframe: 30 Days post ED Discharge

Time from patient arrival to time when patient is officially discharged or admitted

Outcome measures

Outcome measures
Measure
Experimental
n=38 Participants
Gastrointestinal Polymerase Chain Reaction test performed and results communicated to treatment provider. Followed by usual care per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
Control
n=36 Participants
Gastrointestinal Polymerase Chain Reaction test performed at the conclusion of the study. Clinician will not be informed of results. Usual Care performed per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
ED Length of Stay
7.68 hours
Interval 6.43 to 10.67
8.15 hours
Interval 5.9 to 11.23

SECONDARY outcome

Timeframe: 30 Days post ED Discharge

Outcome measures

Outcome measures
Measure
Experimental
n=38 Participants
Gastrointestinal Polymerase Chain Reaction test performed and results communicated to treatment provider. Followed by usual care per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
Control
n=36 Participants
Gastrointestinal Polymerase Chain Reaction test performed at the conclusion of the study. Clinician will not be informed of results. Usual Care performed per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
Hospital Admission Rate
7 Participants
3 Participants

SECONDARY outcome

Timeframe: 30 Days post ED Discharge

Outcome measures

Outcome measures
Measure
Experimental
n=38 Participants
Gastrointestinal Polymerase Chain Reaction test performed and results communicated to treatment provider. Followed by usual care per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
Control
n=36 Participants
Gastrointestinal Polymerase Chain Reaction test performed at the conclusion of the study. Clinician will not be informed of results. Usual Care performed per treating physician. Biofire Film Array Gastrointestinal Panel: The 22-target FilmArray® GI Panel allows a syndromic approach to the diagnosis of infectious diarrhea as it includes bacteria, viruses and parasites in one test. Results are typically available within two hours of collection.
Rate of Abdominal/Pelvic CT Scans
8 Participants
8 Participants

Adverse Events

Experimental

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Andrew Meltzer

George Washington University

Phone: 202-741-2952

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place